Cargando…
LBA79 Dutch oncology COVID-19 Consortium (DOCC): Outcome of COVID-19 in patients with cancer in a nationwide cohort study
Autores principales: | de Joode, K., Dumoulin, D., Tol, J., Westgeest, H., Beerepoot, L., Van den Berkmortel, F., Mutsaers, P., van Diemen, N., Visser, O., Bloemendal, H.J., van Laarhoven, H., Hendriks, L., Haanen, J.B.A.G., de Vries, E.G.E., Dingemans, A-M.C., Van der Veldt, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506434/ http://dx.doi.org/10.1016/j.annonc.2020.08.2320 |
Ejemplares similares
-
Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study
por: de Joode, Karlijn, et al.
Publicado: (2020) -
Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective
por: de Joode, K., et al.
Publicado: (2020) -
LBA8 Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors
por: Oosting, S., et al.
Publicado: (2021) -
Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium
por: de Joode, Karlijn, et al.
Publicado: (2022) -
LBA70_PR The impact of COVID-19 on oncology professionals: Initial results of the ESMO resilience task force survey collaboration
por: Banerjee, S., et al.
Publicado: (2020)